GO
Loading...

Health Care Equipment

More

  • June 16- Edwards Lifesciences Corp said on Monday that U.S. health regulators approved its next generation heart valve replacement system for high risk patients and those deemed too frail to endure open heart surgery.

  • CHICAGO, June 16- Well before Medtronic Inc and Covidien Plc announced their $43 billion merger, the two medical device makers had reached common conclusions about how they needed to change. U.S.-based Medtronic on Sunday said it would buy Covidien and moving its executive headquarters to Ireland to take advantage of lower corporate tax rates.

  • Medtronic says still has room for more acquisitions Monday, 16 Jun 2014 | 11:53 AM ET

    CHICAGO, June 16- Medtronic Inc on Monday said it will remain in the market for promising new technologies even as it absorbs Dublin- based medical device maker Covidien Plc in a $42.9 billion cash-and-stock deal.

  • June 15- U.S. medical device maker Medtronic Inc said on Sunday it had agreed to buy Covidien Plc for $42.9 billion in cash and stock and move its executive base to Ireland in the latest transaction aiming for lower corporate tax rates abroad.

  • June 15- U.S. medical device maker Medtronic Inc said on Sunday it would buy Covidien Plc for $42.9 billion in cash and stock, moving its executive base to Ireland in the latest transaction to seek lower corporate tax rates abroad.

  • June 14- U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.

  • June 14- Medical-device maker Medtronic Inc and rival Covidien Plc are in advanced talks to combine in a deal valued at $45 billion to $50 billion, a source familiar with the matter said on Saturday.

  • PARIS, June 14- French drugmaker Sanofi said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes. Under the terms of a memorandum of understanding, Sanofi and Medtronic will initially cooperate on developing drug-device combinations and offering care management services for diabetes patients.

  • June 14- U.S. medical device maker Medtronic Inc is in advanced talks to merge with rival Covidien Plc in a deal valued at between $45 billion and $50 billion, a person familiar with the matter said on Saturday.

  • Medtronic, Covidien in advanced talks to combine -WSJ Saturday, 14 Jun 2014 | 12:23 PM ET

    June 14- Medical-device maker Medtronic Inc and rival Covidien PLC are in advanced talks to combine in a deal that could be worth more than $40 billion, the Wall Street Journal reported on Saturday, citing people familiar with the matter. Covidien is based in Ireland, which is known for having a relatively low tax rate.

  • PARIS, June 14- French drugmaker Sanofi said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes. Under the terms of a memorandum of understanding, Sanofi and Medtronic will initially cooperate on developing drug-device combinations and offering care management services for diabetes patients.

  • *China launches anti-dumping probe into dialysis kit makers. SHANGHAI, June 13- China on Friday launched an anti-dumping investigation into makers of blood dialysis equipment in the European Union and Japan, including market leader Fresenius Medical Care AG& Co KGaA, challenging the international firms who currently dominate the global and Chinese markets.

  • CHICAGO, June 6- A new way of evaluating tumors may soon help cancer patients identify the underlying genetic link to their disease- and the best possible treatment- all in a single test. "We really are moving away from this one drug, one biomarker, one companion diagnostic," said Dr Richard Pazdur, the U.S. Food and Drug Administration's oncology chief.

  • Medtronic mulls bid for Smith & Nephew: Report Wednesday, 4 Jun 2014 | 3:36 PM ET
    Medtronic office in Toronto.

    One of the world's largest makers of medical devices, Medtronic, is considering a takeover of London-based Smith & Nephew, Bloomberg said.

  • June 4- HeartWare International Inc said it received a warning letter from the U.S. Food and Drug Administration following an inspection of its manufacturing plant in Florida in January. HeartWare has also been asked to address issues related to its production and quality procedures and fix problems cited in FDA's inspection.

  • Medical device maker HeartWare gets FDA warning letter Wednesday, 4 Jun 2014 | 7:37 AM ET

    June 4- HeartWare International Inc said it received a warning letter from the U.S. Food and Drug Administration following an inspection of its manufacturing plant in Florida in January. The FDA has not restricted the use of HeartWare devices, the company said in a statement.

  • May 28- Medtronic Inc has agreed to pay the United States $9.9 million to settle claims that the company used kickbacks to induce doctors to implant its pacemakers and defibrillators in patients, the U.S. Department of Justice said.

  • Medtronic settles U.S. kickbacks case over pacemakers Wednesday, 28 May 2014 | 3:44 PM ET

    May 28- Medtronic Inc has agreed to pay $9.9 million to the United States to settle claims it used kickbacks to induce doctors to implant its pacemakers and defibrillators in patients.

  • May 20- Medtronic Inc agreed to pay more than $1 billion to rival Edwards Lifesciences Corp to settle patent litigation and keep its CoreValve artificial heart valve on the U.S. market. Edwards was first to market with its Sapien technology in 2011 in the United States, while Medtronic received U.S. regulatory approval for CoreValve in January.

  • May 20- Medtronic Inc agreed to pay royalties to rival Edwards Lifesciences Corp so it can continue to sell its CoreValve replacement heart valves, the medical device maker said on Tuesday. Medtronic said it would give Edwards a one-time payment of $750 million, plus ongoing royalty payments through April 2022, based on a percentage of CoreValve sales.